Stuart Naylor

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 436 citations

Medicine, Neuroscience, Pharmacology +16

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

Frances R. Balkwill, Frances Burke, Denis Talbot et al. · The Lancet · 1987 · 425 citations

Medicine, Cancer Biology, Oncology +10

Interaction of Axin and Dvl‐2 proteins regulates Dvl‐2‐stimulated TCF‐dependent transcription

Matthew J. Smalley, Elizabeth Sara, Hugh Paterson et al. · The EMBO Journal · 1999 · 249 citations · Full text

Life Sciences, Genetics, Molecular Biology +6

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Robert J. Amato, Robert E. Hawkins, Howard L. Kaufman et al. · Clinical Cancer Research · 2010 · 197 citations · Full text

Medicine, Oncology, Pharmacology +17

Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study

Peter A. Campochiaro, Andreas Lauer, Elliott H. Sohn et al. · Human Gene Therapy · 2016 · 184 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16